Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

CD8+ T cells from patients with narcolepsy and healthy controls recognize hypocretin neuron-specific antigens

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Combined burden and functional impact tests for cancer driver discovery using DriverPower

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Genomic footprints of activated telomere maintenance mechanisms in cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Pathway and network analysis of more than 2500 whole cancer genomes

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Prenatal dietary supplements influence the infant airway microbiota in a randomized factorial clinical trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Long-term health and socioeconomic consequences of childhood and adolescent-onset of narcolepsy

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The role of sleep in the pathophysiology of nocturnal enuresis

    Research output: Contribution to journalReviewResearchpeer-review

  3. Variant in ERAP1 promoter region is associated with low expression in a patient with a Behçet-like MHC-I-opathy

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Plasma Cotinine Cutoff for Distinguishing Smokers From Nonsmokers Among Persons Living With HIV

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Narcolepsy Type 1 (NT1) is a neurological sleep disorder, characterized by the loss of hypocretin/orexin signaling in the brain. Genetic, epidemiological and experimental data support the hypothesis that NT1 is a T-cell-mediated autoimmune disease targeting the hypocretin producing neurons. While autoreactive CD4+ T cells have been detected in patients, CD8+ T cells have only been examined to a minor extent. Here we detect CD8+ T cells specific toward narcolepsy-relevant peptides presented primarily by NT1-associated HLA types in the blood of 20 patients with NT1 as well as in 52 healthy controls, using peptide-MHC-I multimers labeled with DNA barcodes. In healthy controls carrying the disease-predisposing HLA-DQB1*06:02 allele, the frequency of autoreactive CD8+ T cells was lower as compared with both NT1 patients and HLA-DQB1*06:02-negative healthy individuals. These findings suggest that a certain level of CD8+ T-cell reactivity combined with HLA-DQB1*06:02 expression is important for NT1 development.

Original languageEnglish
Article number837
JournalNature Communications
Volume10
Issue number1
Pages (from-to)837
ISSN2041-1723
DOIs
Publication statusPublished - 1 Dec 2019

    Research areas

  • Adolescent, Adult, CD8-Positive T-Lymphocytes/immunology, Case-Control Studies, Child, Female, Genetic Predisposition to Disease, HLA-DQ beta-Chains/genetics, Humans, Male, Middle Aged, Narcolepsy/genetics, Neurons/metabolism, Orexins/immunology, Peptides/immunology

ID: 58007203